Biocomposites Limited

Phillip Anthony Laycock

John Joseph Cooper

Russell David Waters

John Warren Colclough

Gerhard Maale

John Stephen Bratt

Sean Sydney Aiken

Michael Christopher James Harris

Michael Christopher Harris

John Colclough

The present disclosure concerns a composition for an implantable pharmaceutical composition prepared from components consisting only of calcium sulfate α-hemihydrate in combination with two antibiotics, vancomycin and gentamicin, for the treatment of infection in bone and soft tissue.

Implantable pharmaceutical composition prepared from components consisting of calcium sulfate alpha-hemihydrate, vancomycin and gentamicin

Disclosed is a device for implantation into a bone void while minimising the potential for an increase in pressure within the bone void.

Device to fill a bone void whilst minimising pressurisation

Disclosed is an invention that provides a method of treating a bone void of a patient through the use of an implantable device whilst minimising the potential for an increase in pressure within the bone void thus avoiding embolization of the void contents into the patient's bloodstream.

Method to introduce an implantable device to fill a bone void whilst minimising pressurisation

A means to prepare bone cement pellets comprising bone cement paste which hardens through hydration a flexible mold mat having pellet cavities on both sides and a scraper for pasting the bone cement paste in to the pellet cavities where the paste is allowed to harden.

Growing community of inventors

Keele, United Kingdom

Phillip Anthony Laycock